ISPOR Dubai 2018 Announced for 19-20 September 2018

Healthcare Decision Making in the Middle East and North Africa

Lawrenceville, NJ, USA—April 23, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced a new conference, ISPOR Dubai 2018 scheduled for 19-20 September 2018 in Dubai, United Arab Emirates. ISPOR Dubai 2018 will be the first regional conference of its type that the Society is organizing and will focus on the theme, “Healthcare Decision Making in the Middle East and North Africa: The Role of Health Economics and Outcomes Research and Health Technology Assessment.” The conference will bring together regional and international experts and stakeholders in HEOR to share innovative research methods and health policy developments. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

ISPOR Announces Honorees for 2018 Awards Program

Global Leaders in Health Economics and Outcomes Research Honored

Lawrenceville, NJ, USA—April 9, 2018—ISPOR, the professional society for health economics and outcomes research, announced today the honorees for its 2018 Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR) and its Leadership Awards recognize excellence and outstanding leadership in the field. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Study: Real-World Evidence has Limited Use in Managed Care Formulary Decision Making

Value in Health Report Examines Payers’ Perceptions, Practices

Lawrenceville, NJ, USA—April 3, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that while payers recognize the value of real-world evidence (RWE), the use of such studies to inform pharmacy and therapeutic (P&T) committee decisions is limited. The report of these findings, Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?, was published in the March 2018 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

New Drugs and Medical Technologies Often Deemed “Cost-Effective but Unaffordable”

Experts Offer Pragmatic Approaches to Managing Tension Between Affordability and Cost-Effectiveness

Lawrenceville, NJ, USA—March 27, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a series of articles centered on affordability in healthcare. The special themed section, introduced by an editorial entitled Affordability of New Technologies: The Next Frontier, appears in the March 2018 issue of Value in Health. The guest editors for this themed section are Adrian Towse, MA, MPhil, Office of Health Economics, London, England, United Kingdom and Josephine Mauskopf, PhD, RTI International, Research Triangle Park, NC, USA.

The themed section includes 3 articles and 2 commentaries that examine the issue of affordability from different perspectives:

  • Affordability Challenges to Value-Based Pricing: Mass Diseases, Orphan Diseases, and Cures. Focusing on 3 specific contexts, Patricia Danzon, PhD, analyzes how value-based pricing can manage “affordability” challenges, defined as drugs that meet cost-effectiveness thresholds but are “unaffordable” within the short-run budget. Danzon argues that cost-effectiveness and budgets are linked but that over time the budget can adjust if people want it to.
  • The ICER Value Framework: Integrating Cost-Effectiveness and Affordability in the Assessment of Health Care Value. Steven D. Pearson, MD, MSc recounts the experience of seeing Sovaldi identified as ‘low value’ by his advisory committee members because the budget impact was “so significant that it over-rode what was acknowledged to be excellent cost effectiveness.” He details the journey that the Institute for Clinical Economic Review took in moving to adjust the price of a new treatment to reflect budget impact over and above the assessment of cost-effectiveness.
  • Paying for Cures: Perspectives on Solutions to the “Affordability Issue.” Sarah Schaffer, MSc and colleagues provide a commentary that reviews innovative payment solutions to address the affordability issue, drawing on discussions with payers in the United States and Europe on the feasibility of implementing any of these alternative solutions. They conclude that for the foreseeable future, affordability pressures will continue to be handled by aggressive price bargaining, high co-pays (in systems where this is possible), and restricting access to subgroups of patients.
  • Affordability of Health Care: A Global Crisis. In his commentary, John Watkins, PharmD, MPH, BCPS introduces and addresses several implicit affordability assumptions that should receive further scrutiny. Watkins calls for finding ways to eliminate paying for low-value products and unnecessary medical care, limiting the cost increases of high-value products, improving the efficiency of care delivery systems, and helping the public to understand the true societal impact of inefficiency.

Considering the points and perspectives raised in this collection of papers, Towse and Mauskopf reach several conclusions: 1) affordability matters, 2) more research is needed to understand the dynamics of healthcare affordability, 3) payer reluctance to adopt value-for-money treatments with high budget impact is understandable but risks distorting resource allocation, and 4) overall efficiency in healthcare needs to be improved.

###

 

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2016 impact factor score is 4.235. Value in Health is ranked 3rd out of 77 journals in health policy and services, 7th out of 347 journals in economics, and 9th out of 90 journals in healthcare sciences and services. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: www.ispor.org/valueinhealth_index.asp | Twitter: www.twitter.com/ISPORJournals (@ISPORjournals)

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , , ,

New Training Programs in Health Economics and Outcomes Research Announced

ISPOR’s Essential HEOR Education Program Schedule Now Open for Registration


Lawrenceville, NJ, USA
—March 19, 2018—ISPOR, the professional society for health economics and outcomes research, announced the opening of training programs scheduled for the first half of 2018. ISPOR’s Essential HEOR Training Program provides professional training and education in the field of health economics and outcomes research (HEOR) that covers a wide variety of course topics. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

Conference Theme and Plenary Speakers Announced for ISPOR 2018

Society’s Conference to Focus on Real-World Evidence and Digital Health

Lawrenceville, NJ, USA—March 13, 2018—ISPOR, the professional society for health economics and outcomes research, announced plenary sessions and speakers for ISPOR 2018. The conference is scheduled for May 19-23, 2018 in Baltimore, MD, USA and will focus on the timely theme, “Real-Word Evidence, Digital Health, and the New Landscape for Health Decision Making.” Cochairs for the conference are C. Daniel Mullins, PhD, University of Maryland School of Pharmacy, Baltimore, MD, USA and Rachael L. Fleurence, PhD, National Evaluation System for Health Technology Coordinating Center, Arlington, VA, USA. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

New “Top 10 Trends in Health Economics and Outcomes Research” Webinar Announced

ISPOR to Report on Top Trends Impacting Healthcare in 2018 and Beyond


Lawrenceville, NJ, USA
—March 6, 2018—ISPOR, the professional society for health economics and outcomes research, announced today that registration is now open for a new webinar that reviews the, “Top 10 Trends in Health Economics and Outcomes Research.” This free webinar will be held on March 27, 2018 at 11:00 AM EDT and will provide an overview of the Society’s recent report on the top trends in health economics and outcomes research that will likely have the most impact on healthcare in 2018 and beyond. Read more ›

Posted in Announcements, ISPOR News & Press Tagged with: ,

New Study Shows Most Women Willing to Accept the Risks of Breast Screening

Value in Health Report Quantifies Women’s Preferences

Lawrenceville, NJ, USA—February 27, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that, on average, most women were willing to accept the risk of unnecessary follow-ups for an increased chance of detecting a cancer in screening. The report of these findings, Investigating the Heterogeneity in Women’s Preferences for Breast Screening: Does the Communication of Risk Matter? was published in the February 2018 issue of Value in Health. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Special Task Force Provides Recommendations for Measuring and Communicating the Value of Pharmaceuticals and Other Technologies in the US

Report Calls for Development of a More Comprehensive Economic Evaluation

Lawrenceville, NJ, USA—February 26, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a series of articles presenting and discussing the findings of the ISPOR Special Task Force on US Value Assessment Frameworks, which was co-chaired by Lou Garrison, PhD, University of Washington, and Peter Neumann, ScD, Tufts Medical Center. Read more ›

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , ,

ISPOR Announces a Brand Refresh for the Society

The New Look was Created to Better Reflect as the Society as the
Field of Health Economics and Outcomes Research Evolves

Lawrenceville, NJ, USA—February 13, 2018—ISPOR, the professional society for health economics and outcomes research, announced today the launch of its new branding. Read more ›

Posted in Announcements, ISPOR News & Press